Literature DB >> 18097583

Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character.

Masanori Yasuda1, Masaki Miyazawa, Mariko Fujita, Hiroshi Kajiwara, Tetsuji Iida, Takeshi Hirasawa, Toshinari Muramatsu, Masaru Murakami, Mikio Mikami, Kaoru Saitoh, Michio Shimizu, Susumu Takekoshi, R Yoshiyuki Osamura.   

Abstract

The expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) was immunohistochemically analyzed in ovarian adenocarcinomas with the aim of elucidating whether hypoxic status is associated with histological type or structural character. The following ovarian adenocarcinomas were used: serous adenocarcinoma (SEA), 21 cases; mucinous adenocarcinoma (MUA), 19 cases; endometrioid adenocarcinoma (ENA), 16 cases; clear cell adenocarcinoma (CLA), 19 cases. High-level expression (3+) of HIF-1alpha was observed in 100% of SEAs, 58% of MUAs, 100% of ENAs and 89% of CLAs, and high-level expression of GLUT-1 in 76% of SEAs, 26% of MUAs, 50% of ENAs and 67% of CLAs. Heterogeneous or localized staining was relatively evident for GLUT-1. Immunohistochemical profiles were in accord with the immunoblotting and mRNA levels of both markers. ELISA for the detection of active HIF-1 demonstrated that HIF-1 is strongly activated in SEAs, ENAs and CLAs as compared to MUAs. Our results show that GLUT-1 overexpression is to some extent regulated by HIF-1alpha and is also strongly associated with histological features, i.e., papillary or stratified structure accompanied by little or no vascular stroma. In conclusion, hypoxic status differs according to the histological type of ovarian adenocarcinoma and the micro-environmental conditions of each type.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097583

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

1.  Correlation and expression analysis of hypoxia-inducible factor 1α, glucose transporter 1 and lactate dehydrogenase 5 in human gastric cancer.

Authors:  Lang-Song Hao; Qi Liu; Chuan Tian; Dong-Xing Zhang; Bo Wang; Dong-Xu Zhou; Zhao-Peng Li; Zhi-Xiang Yuan
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

Review 2.  Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier.

Authors:  Diane C Lim; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-03-28       Impact factor: 11.609

3.  Pathological and prognostic significance of hypoxia-inducible factor 1α expression in epithelial ovarian cancer: a meta-analysis.

Authors:  Yue Jin; Haolu Wang; Xiaowen Liang; Jun Ma; Yu Wang
Journal:  Tumour Biol       Date:  2014-05-21

4.  Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma.

Authors:  Xiao-Hong Wu; Su-Ping Chen; Jian-Ying Mao; Xue-Xian Ji; Hong-Tian Yao; Shui-Hong Zhou
Journal:  Oncol Lett       Date:  2012-09-26       Impact factor: 2.967

5.  Hereditary ovarian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxidative stress and NFκB activation in the tumor stroma.

Authors:  Ubaldo E Martinez-Outschoorn; Renee M Balliet; Zhao Lin; Diana Whitaker-Menezes; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2012-10-09       Impact factor: 4.534

6.  An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway.

Authors:  Sohei Yamamoto; Hitoshi Tsuda; Kozue Suzuki; Masashi Takano; Seiichi Tamai; Osamu Matsubara
Journal:  Virchows Arch       Date:  2009-08-05       Impact factor: 4.064

7.  Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma.

Authors:  Hitomi Tsukada; Toshinari Muramatsu; Masaki Miyazawa; Tetsuji Iida; Masae Ikeda; Masako Shida; Takeshi Hirasawa; Hiroshi Kajiwara; Masaru Murakami; Masanori Yasuda; Mikio Mikami
Journal:  Acta Histochem Cytochem       Date:  2012-04-21       Impact factor: 1.938

8.  Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible factor 1α expression: a meta-analysis including 6,612 subjects.

Authors:  Yue Jin; Haolu Wang; Xiaowei Ma; Xiaowen Liang; Xin Liu; Yu Wang
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

9.  Prognostic Relevance of the Expression of CA IX, GLUT-1, and VEGF in Ovarian Epithelial Cancers.

Authors:  Kyungbin Kim; Won Young Park; Jee Yeon Kim; Mee Young Sol; Dong Hun Shin; Do Youn Park; Chang Hun Lee; Jeong Hee Lee; Kyung Un Choi
Journal:  Korean J Pathol       Date:  2012-12-26

10.  An up-to-date anti-cancer treatment strategy focusing on HIF-1alpha suppression: its application for refractory ovarian cancer.

Authors:  Mariko Fujita; Masanori Yasuda; Kanae Kitatani; Masaki Miyazawa; Kenichi Hirabayashi; Susumu Takekoshi; Tetsuji Iida; Takeshi Hirasawa; Masaru Murakami; Mikio Mikami; Isamu Ishiwata; Michio Shimizu; R Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2007-12-18       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.